- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05152030
The Clinical Applicability of the 'TIB' Olfactory Test Device
November 26, 2021 updated by: Taichung Veterans General Hospital
Validation of the Local Applicability of the 'TIB' Olfactory Test Device in the Era of COVID-19
The aim of this study was to evaluate the validity and test-retest reliability of the 'TIB' Olfactory Test Device, a new olfactory test tool developed by Top International Biotech, Taipei, and to determine its normative values.
The olfactory function of 180 subjects was evaluated using both the traditional Chinese version of the University of Pennsylvania of Smell Identification Test (UPSIT-TC) and TIB.
The subjects consisted of 60 healthy volunteers (normosmic group), 60 hyposmic patients, and 60 anosmic patients.
The healthy volunteers were retested with the UPSIT-TC and TIB at an inter-test interval of at least 7 days.
The cut-off scores of TIB among the different groups were determined by receiver operating characteristic curve.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
180
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taichung, Taiwan, 407219
- Taichung Veterans General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 59 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Normosmic group were from community.
Hyposmic and anosmic patients were from out patient clinic department of Otorhinolaryngology.
Description
Inclusion Criteria:
- Normosmic group were self-reported absence of deficits in olfaction. Hyposmic patients were loss of olfactory function with a phenyl ethyl alcohol (PEA) odor detection threshold below -1. Anosmic patients were loss of olfactory function with a PEA threshold equal to -1.
Exclusion Criteria:
- History of sinonasal symptoms within a week before the test
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
hyposmic patients
|
A new smell identification test, 'TIB' Olfactory Test Device (Top International Biotech, Taipei) has been developed in Taiwan.
It consists of 16 tests with an odorant embedded in fragrant microcapsules positioned on a strip.
The examinee scratches the strip to release the odorant.
The released odorant is sniffed and the examinee identifies the odorant by choosing a name from a set of 4 odor descriptors.
This process is then repeated with the next odorant on the strip.
The University of Pennsylvania Smell Identification Test (UPSIT), which was developed at the University of Pennsylvania, is one of the most reliable and the most widely used olfactory test.The test consists of four 10-odorant booklets.
Each odorant is embedded in 10 to 50 µm urea-formaldehyde polymer microencapsules fixed in a proprietary binder and positioned on a brown strip which is located at the bottom of each page of the test booklet.4
When the examinee takes the test, each of the 40 odorants is released by scratching the strip with a pencil tip.
The released odorant is sniffed and the examinee identifies the odorant by choosing a name from a set of 4 odor descriptors.
|
anosmic patients
|
A new smell identification test, 'TIB' Olfactory Test Device (Top International Biotech, Taipei) has been developed in Taiwan.
It consists of 16 tests with an odorant embedded in fragrant microcapsules positioned on a strip.
The examinee scratches the strip to release the odorant.
The released odorant is sniffed and the examinee identifies the odorant by choosing a name from a set of 4 odor descriptors.
This process is then repeated with the next odorant on the strip.
The University of Pennsylvania Smell Identification Test (UPSIT), which was developed at the University of Pennsylvania, is one of the most reliable and the most widely used olfactory test.The test consists of four 10-odorant booklets.
Each odorant is embedded in 10 to 50 µm urea-formaldehyde polymer microencapsules fixed in a proprietary binder and positioned on a brown strip which is located at the bottom of each page of the test booklet.4
When the examinee takes the test, each of the 40 odorants is released by scratching the strip with a pencil tip.
The released odorant is sniffed and the examinee identifies the odorant by choosing a name from a set of 4 odor descriptors.
|
normosmic group
|
A new smell identification test, 'TIB' Olfactory Test Device (Top International Biotech, Taipei) has been developed in Taiwan.
It consists of 16 tests with an odorant embedded in fragrant microcapsules positioned on a strip.
The examinee scratches the strip to release the odorant.
The released odorant is sniffed and the examinee identifies the odorant by choosing a name from a set of 4 odor descriptors.
This process is then repeated with the next odorant on the strip.
The University of Pennsylvania Smell Identification Test (UPSIT), which was developed at the University of Pennsylvania, is one of the most reliable and the most widely used olfactory test.The test consists of four 10-odorant booklets.
Each odorant is embedded in 10 to 50 µm urea-formaldehyde polymer microencapsules fixed in a proprietary binder and positioned on a brown strip which is located at the bottom of each page of the test booklet.4
When the examinee takes the test, each of the 40 odorants is released by scratching the strip with a pencil tip.
The released odorant is sniffed and the examinee identifies the odorant by choosing a name from a set of 4 odor descriptors.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
validity of TIB olfactory test
Time Frame: 30 minutes to 1 hour
|
Criterion validity: Correlation between UPSIT-TC and TIB olfactory test
|
30 minutes to 1 hour
|
Reliability of TIB olfactory test
Time Frame: 1 week
|
Test-retest reliability
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Rong-San Jiang, M.D., Ph.D., Taichung Veterans General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 1, 2020
Primary Completion (ACTUAL)
August 31, 2021
Study Completion (ACTUAL)
September 16, 2021
Study Registration Dates
First Submitted
November 26, 2021
First Submitted That Met QC Criteria
November 26, 2021
First Posted (ACTUAL)
December 9, 2021
Study Record Updates
Last Update Posted (ACTUAL)
December 9, 2021
Last Update Submitted That Met QC Criteria
November 26, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CE20329A#1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anosmia
-
University Hospital, Strasbourg, FranceCompletedChronic Rhinosinusitis | Post-viral Anosmia | Post-traumatic Anosmia | Idiopathic Anosmia | Age-related Loss of SmellFrance
-
Taichung Veterans General HospitalCompletedTraumatic AnosmiaTaiwan
-
Danish Dementia Research CentreDanish Reference Center for Prion Diseases, Rigshospitalet; Department of Otorhinolaryngology...RecruitingIdiopathic Anosmia | Idiopathic Hyposmia | Idiopathic Olfactory DysfunctionDenmark
-
Cyrano Therapeutics, Inc.Recruiting
-
Washington University School of MedicineWithdrawn
-
Manchester University NHS Foundation TrustWithdrawn
-
Deraya UniversityCompleted
-
Rockefeller UniversityCompletedSpecific AnosmiasUnited States
-
Central Hospital, Nancy, FranceUnknown
Clinical Trials on 'TIB' Olfactory Test
-
Centre Hospitalier Universitaire de NiceWithdrawnOlfaction Disorders | COVID-19 TestingFrance
-
Jewish General HospitalCompletedAlzheimer Disease | Olfaction DisordersCanada
-
Cliniques universitaires Saint-Luc- Université...CompletedFrailty | Perioperative/Postoperative Complications | Olfactory DisorderBelgium
-
University of GiessenUniversity of Kiel; Masaryk UniversityRecruitingDysgeusia | Olfactory Disorder | Oral ComplicationGermany
-
Cliniques universitaires Saint-Luc- Université...Active, not recruitingNeurocognitive Disorders | Postoperative Cognitive Dysfunction | Frailty | Perioperative/Postoperative Complications | Olfactory DisorderBelgium
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompletedPeople With Normal Sense of SmellNorway
-
Cristina Gomez CaleroCompletedBrain Injuries, Traumatic | Anosmia | Occupational TherapySpain
-
Hôpital de ViegeCompletedMild Traumatic Brain Injury
-
Chang Gung Memorial HospitalRecruitingPostoperative Complications | Enhanced Recovery After Surgery | Pituitary TumorTaiwan
-
University Hospital, CaenNot yet recruitingAdult With Stroke and Olfaction's Complaint